comparative efficacy of combined treatment with intron a and pegintron in combination with ribavirin in patients with chronic hepatitis С
Clicks: 230
ID: 155129
2004
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
230 views
23 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #23 of 34 articles by views in indian journal of chemical technology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Aim. To investigate the efficacy of combined therapy of patients with chronic hepatitis С (СНС) including intron A, pegintron (preparations of alpha-2b interferon) and ribavirin, and evaluation of the above treatment side effects.
Material and methods. 47 СП С patients (38 males and 9 females) were divided into two groups. 22 patients of group 1 received intron A and ribavirin, 25 patients of group 2 were given pegintron and ribavirin for 6-12 months. The examination made before the treatment, during the treatment and after it included clinical, biochemical, virusological blood tests, tests for autoantibodies, thyroid hormones, ultrasound investigation.
Results. The response in group 1 was 55%, in group 2 - 72.7%. In group 2, CNS and skin side effects occurred more frequently. After the treatment side effects regressed in 95.8% patients. Conclusion. The pilot experience in Russia confirmed the findings of the foreign investigators on higher efficacy of combined treatment with pegilized interferons (pegintron) and ribavirin vs combination of intron A with ribavirin. It is shown that side effects of the above treatment can be corrected in outpatient medication.
| Reference Key |
gromova2004comparative
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;N I Gromova;B P Bogomolov |
| Journal | indian journal of chemical technology |
| Year | 2004 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.